Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Boston Scientific to Pay Johnson & Johnson $1.7 Billion in Stent Settlements
|
Wade Roush |
02/01/10 |
Boston
|
|
Sequenom Settles Shareholder Lawsuit for $14M, Plus Stock
|
Luke Timmerman |
01/15/10 |
San Diego
|
|
The Intellectual Property Century
|
Steve Davis |
01/11/10 |
National
|
|
Sequenom Down Syndrome Results “Deliberately Doctored,” Says Partner Xenomics
|
Luke Timmerman |
12/17/09 |
San Diego
|
|
Report: SEC Probing 3Com for Potential Insider Trading
|
Wade Roush |
11/16/09 |
Boston
|
|
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
Stryker Biotech Division Indicted for FDA Fraud by Massachusetts Grand Jury
|
Luke Timmerman |
10/28/09 |
Boston
|
|
Sequenom Settles Ibis Dispute
|
Luke Timmerman |
10/27/09 |
San Diego
|
|
Sonosite Gets $21M From GE
|
Luke Timmerman |
10/19/09 |
Seattle
|
|
Legislators Hear Testimony on Non-Compete Restrictions
|
Amrith Kumar |
10/08/09 |
Boston
|
|
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/06/09 |
Seattle
|
|
On Verge of Omeros IPO, Former Finance Chief Accuses Company of Filing False Records with NIH
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
Hearings on Non-Compete Restrictions Set for Next Week
|
Wade Roush |
09/30/09 |
Boston
|
|
Boston Scientific Pays $716M to Settle Patent Dispute with J&J
|
Luke Timmerman |
09/29/09 |
Boston
|
|
Zintro’s Pay-by-the-Call Service Connects Investors, Others with Industry Experts
|
Wade Roush |
09/29/09 |
Boston
|
|
Life Tech and Illumina, Two San Diego Biotech Giants, in Patent Dispute
|
Denise Gellene |
09/24/09 |
San Diego
|
|
New Speech Recognition Engine Under the Hood at Vlingo; Startup Dumps IBM and Nuance for AT&T
|
Wade Roush |
09/16/09 |
Boston
|
|
EMC to Buy Kazeon
|
Wade Roush |
09/01/09 |
Boston
|
|
The Webloyalty Settlement: A Great Graphic Lesson in Marketing Practices
|
Robert Buderi |
08/28/09 |
Boston
|
|
Webloyalty Customers Eligible for Payments Under Class-Action Settlement
|
Wade Roush |
08/27/09 |
Boston
|
|
Making Connections, Managing Risk in Startup Deals: A Visit to Boston Law Firm Mintz Levin
|
Wade Roush |
08/25/09 |
Boston
|
|
Amazon, Microsoft Join Against Google Books Deal
|
Eric Hal Schwartz |
08/21/09 |
Seattle
|
|
Do Non-Competes Curtail Startup Investments? Brownsberger and Rowe Do A Data Dive and Kick Off A Deeper Discussion
|
Robert Buderi |
08/10/09 |
Boston
|
|
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J
|
Ryan McBride |
08/06/09 |
Boston
|
|
Genzyme Faces Lawsuit and Competition, Vertex Gathers More Cash for Telprevir, Cardiorobotics Corrals $11.6M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
08/05/09 |
Boston
|
|
Patrick Administration Questions the Case for Changing Noncompetes; Community Reacts
|
Wade Roush |
07/29/09 |
Boston
|
|
Massachusetts Has “One Foot in the 21st Century, One Foot in the 18th,” Says Attorney General Coakley
|
Wade Roush |
07/28/09 |
Boston
|
|
Revised Noncompete Legislation Doesn’t Go Far Enough
|
Bijan Sabet |
07/20/09 |
Boston
|
|
Compromise Bill Would Allow, But Scale Back, Noncompete Agreements in Massachusetts
|
Wade Roush |
07/20/09 |
Boston
|
|
Tragedy of the Commons: It’s (Really) Time to Ban Non-Compete Agreements
|
Tim Rowe |
07/15/09 |
Boston
|
|
Page 1 of
5 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
